Clinical Trials Browser

Terminated × OTHER × MART-1 Antigen × Clear all

NCT00005841 2014-05-22

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1 Terminated

Uveal Melanoma, Melanoma

NCT00006113 2014-05-22

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Terminated

Melanoma